Pieris Pharmaceuticals’ Inhaled IL4Ra Antagonist Shows Promise As Severe Asthma Therapy
Asthma, News
Professor Gary Anderson, PhD, FThorSoc, FERS, and Director of the Lung Health Research Centre at the University of Melbourne recently revealed preclinical data related to PRS-060, Pieris Pharmaceuticals’ new inhaled ... Read more